Template:Phototherapy guidelines: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 44: | Line 44: | ||
*Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors) | *Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors) | ||
*High Risk: 35-37 weeks + risk factors | *High Risk: 35-37 weeks + risk factors | ||
;Phototherapy is only used for an indirect hyperbilirubinemia | |||
Latest revision as of 21:17, 1 July 2021
Phototherapy guidelines for neonatal jaundice
| Age | Low Risk | Medium Risk | High Risk |
| Birth | 7.0 | 5.0 | 4.0 |
| 24h | 11.5 | 9.0 | 8.0 |
| 48h | 15 | 14 | 10 |
| 72h | 17.5 | 15 | 14 |
| 96h | 20 | 17.5 |
14.5 |
| 5+days | 21 | 17.5 | 15 |
- Low Risk: ≥38 weeks + no risk factors
- Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors)
- High Risk: 35-37 weeks + risk factors
- Phototherapy is only used for an indirect hyperbilirubinemia